Results 1 to 10 of about 10,975 (245)

Ocular myasthenia gravis management [PDF]

Frontiers in Neurology
Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith, Gil I. Wolfe, Henry Kaminski   +2 more
doaj   +5 more sources

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis [PDF]

Journal of Ophthalmology, 2014
Aim. To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis. Methods. In total, 144 patients complaining of fluctuating diplopia and ptosis were evaluated for serum levels
Jung Jin Lee, Kyung Min Koh, Ungsoo Samuel Kim   +2 more
doaj   +2 more sources

Ocular myasthenia gravis in a setting of thyrotoxicosis

Indian Journal of Endocrinology and Metabolism, 2013
Ocular myasthenia gravis in conjunction with thyroid disorders, although rare, has been reported in the past. However, the similarity in the presentation of both the entities and the tendency of myasthenia gravis to get overlooked easily, even by ...
Sarabjeet Chhabra, B C Pruthvi
doaj   +2 more sources

Ocular myasthenia gravis [PDF]

Russian Annals of Ophthalmology
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as ...
M.S. Sergeeva, S.S. Danilov, N.I. Sherbakova   +2 more
  +5 more sources

New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report [PDF]

Journal of Family Medicine and Primary Care, 2023
Reports have shown the association of coronavirus disease 2019 (COVID-19) with several neuromuscular disorders. Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetyl choline receptors in the postsynaptic membrane at the ...
Himani T. Chaturvedi, Varsha Patel, Rahul Vasava, Chandrashekher Chaturvedi   +3 more
doaj   +2 more sources

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis [PDF]

American Journal of Perinatology Reports, 2016
Background Myasthenia gravis (MG) is an autoimmune disorder with fluctuating muscle weakness, divided into generalized and localized (ocular) forms.
Courtney Townsel, Rebecca Keller, Kendall Johnson, Naveed Hussain, Winston A. Campbell   +4 more
doaj   +2 more sources

Add‐On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real‐World Case Series [PDF]

Brain and Behavior
Introduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Jing Lin, Yue Li, Mengcui Gui, Bitao Bu, Zhijun Li   +4 more
doaj   +2 more sources

The Spurious Palsy-Fluctuation of Ocular Myasthenia Gravis Symptoms Characterized by Orthoptics. [PDF]

J Neuroophthalmol
Grimm SL, Fierz FC, Bockisch CJ, Weber KP.   +3 more
europepmc   +2 more sources

Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study [PDF]

Clinical Ophthalmology
Parinee Kemchoknatee,1 Boonravee Santitamrongvtit,2 Thansit Srisombut3 1Department of Ophthalmology, Rajavithi Hospital, Rangsit University, Bangkok, Thailand; 2Department of Medicine, Phra Nang Klao Hospital, Nonthaburi, Thailand; 3Department of ...
Kemchoknatee P, Santitamrongvtit B, Srisombut T   +2 more
doaj   +2 more sources

Juvenile Ocular Myasthenia Gravis in a 3-Year-Old African Girl: A Case Report. [PDF]

Case Rep Ophthalmol
Ngowi E, Lusheke H, Mbuma R, Juneja Z, Mbuki M, Thaver SP, Magodi T, Osman R, Salum H.   +8 more
europepmc   +2 more sources